Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
Family days out have never been more pricey, so getting good value for your money can be hard if you don’t know where to look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results